Literature DB >> 8293953

Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs.

H Kaminishi1, T Cho, T Itoh, A Iwata, K Kawasaki, Y Hagihara, H Maeda.   

Abstract

Porphyromonas gingivalis protease, which had been isolated from a culture supernatant, caused vascular permeability enhancement in a dose-dependent manner when injected into guinea pig skin. The permeability-enhancing reaction caused by the protease was not affected by treatment with antihistamine, but was greatly augmented by simultaneous injection of a kinin potentiator, carboxypeptidase N inhibitor. However, the reaction was inhibited by soybean trypsin inhibitor or alpha 2-antiplasmin, although both of these inhibitors could not inhibit P. gingivalis protease at all by themselves. A bradykinin-degrading enzyme, carboxypeptidase B, weakened this vascular reaction. Results described indicate that the permeability-enhancing reaction induced by the protease is caused by activation, of the kallikrein-kinin cascade in the tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8293953     DOI: 10.1111/j.1574-6968.1993.tb06559.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo.

Authors:  I Rubinstein; J Potempa; J Travis; X P Gao
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist.

Authors:  K Maruo; T Akaike; T Ono; H Maeda
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.

Authors:  Małgorzata Benedyk; Piotr Mateusz Mydel; Nicolas Delaleu; Karolina Płaza; Katarzyna Gawron; Aleksandra Milewska; Katarzyna Maresz; Joanna Koziel; Krzysztof Pyrc; Jan Potempa
Journal:  J Innate Immun       Date:  2015-11-28       Impact factor: 7.349

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.